The new ABUS (automated breast ultrasound) offerings expand the Chicago-based company’s breast imaging portfolio with solutions designed to support supplemental screening for women with dense breasts, providing more flexible enterprise-wide exam review.

GE HealthCare said its new FDA-cleared solutions aim to help breast imaging programs standardize 3D ultrasound acquisition, support remote reading and simplify deployment across multi-site networks.

When used alongside mammography, Invenia ABUS Prime supports earlier cancer detection. GE HealthCare says it helps support standardized exams, more efficient workflows and operational consistency. It particularly achieves this in multi-site imaging environments.